Home
News
Interviews
Companies
Videos
Markets
Subscribe
The
Latest
The Latest
Psychedelics
Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product
Technology
CloudMD Announces Closing of MindBeacon Acquisition, Creating One of North America’s Most Comprehensive Integrated Health Offerings
Healthcare
WELL Health to Participate in Upcoming Investor Conferences
Cannabis
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary
More Articles
FEATURED
Wellfield Outlines 2022 Focus - Providing Services and Applications to Unlock the Power of Decentralized Finance (DeFi)
News
Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies
News
MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin
Trending
#
News
-
Psychedelics
Numinus Wellness Commends Health Canada on Special Access Programme Amendments to Restore Potential Access to Psychedelic Medicines
#
News
-
Crypto
Looking Glass Labs' Subsidiary House of Kibaa Joins DigiBC to Advance NFT and Metaverse Opportunities in British Columbia
#
News
-
Technology
Perimeter Medical Imaging AI Announces Initiation of Additional Clinical Trial Site at Baylor College of Medicine in Houston, TX
#
News
-
Psychedelics
MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD
#
News
-
Technology
Perimeter Medical Imaging AI Announces First Commercial Installation of Perimeter S-Series OCT in North Texas and Ongoing Market Development Activities Across the U.S.
Companies
#
TAAT Global Alternatives Inc.
TAAT
TOBAF
2TP2
Private Company
#
NEXE Innovations
NEXE
Private Company
#
Willow Biosciences
WLLW
CANSF
Private Company
#
Mind Medicine (MindMed)
MMED
Private Company
#
Aequus Pharmaceuticals
AQS
AQSZF
Private Company
